Zhao, T., Jin, F., Xiao, D., Wang, H., Huang, C., Wang, X., . . . Hao, J. (2020). IL-37/ STAT3/ HIF-1α negative feedback signaling drives gemcitabine resistance in pancreatic cancer. Theranostics.
Chicago Style CitationZhao, Tiansuo, et al. "IL-37/ STAT3/ HIF-1α Negative Feedback Signaling Drives Gemcitabine Resistance in Pancreatic Cancer." Theranostics 2020.
Cita MLAZhao, Tiansuo, et al. "IL-37/ STAT3/ HIF-1α Negative Feedback Signaling Drives Gemcitabine Resistance in Pancreatic Cancer." Theranostics 2020.
Atenció: Aquestes cites poden no estar 100% correctes.